Aldo Scarpa
Impact in
- Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
Papers in
- Oncology 392
- Pancreatic and Hepatic Oncology Research 251
- Lung Cancer Research Studies 69
- Cancer Research 146
- Cancer Genomics and Diagnostics 105
- Co-authors
- Massimo Falconi (55 shared papers)Giuseppe Zamboni (79 shared papers)Paola Capelli (71 shared papers)Claudio Luchini (109 shared papers)Carlo Maria Croce (11 shared papers)George A. Călin (3 shared papers)Stefano Volinia (3 shared papers)Chang‐Gong Liu (2 shared papers)
- Journals
- Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (40 papers)Annals of Oncology (23 papers)Nature Communications (19 papers)Pancreatology (19 papers)Oncotarget (19 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Aldo Scarpa
792 papers receiving 64.8k citations
Aldo Scarpa's Hit Papers
Peers
Comparison fields: 5 of 201
- Cancer Research 18.4k
- Oncology 27.5k
- Epidemiology 13.3k
- Neurology 5.3k
- Molecular Biology 21.9k
Countries citing papers authored by Aldo Scarpa
This map shows the geographic impact of Aldo Scarpa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Scarpa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Scarpa more than expected).
Fields of papers citing papers by Aldo Scarpa
This network shows the impact of papers produced by Aldo Scarpa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Scarpa. The network helps show where Aldo Scarpa may publish in the future.
Co-authors
The 25 scholars most cited alongside Aldo Scarpa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 814 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A microRNA expression signature of human solid tumors defines cancer gene targets Hit paper breakdown → | 2006 | 4965 |
| 2 | Genomic analyses identify molecular subtypes of pancreatic cancer Hit paper breakdown → | 2016 | 2794 |
| 3 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 4 | Whole genomes redefine the mutational landscape of pancreatic cancer Hit paper breakdown → | 2015 | 2115 |
| 5 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 6 | International network of cancer genome projects Hit paper breakdown → | 2010 | 1836 |
| 7 | Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes Hit paper breakdown → | 2012 | 1704 |
| 8 | TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Hit paper breakdown → | 2006 | 1268 |
| 9 | Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group Hit paper breakdown → | 2020 | 869 |
| 10 | A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal Hit paper breakdown → | 2018 | 825 |
| 11 | ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach Hit paper breakdown → | 2019 | 803 |
| 12 | Whole-genome landscape of pancreatic neuroendocrine tumours Hit paper breakdown → | 2017 | 774 |
| 13 | TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system Hit paper breakdown → | 2007 | 766 |
| 14 | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma Hit paper breakdown → | 2017 | 735 |
| 15 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 16 | 2006 | 684 | |
| 17 | Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2003 | 626 |
| 18 | Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas Hit paper breakdown → | 2013 | 566 |
| 19 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 20 | 1999 | 532 |
About Aldo Scarpa
Aldo Scarpa is a scholar working on Oncology, Cancer Research, Epidemiology, Pathology and Forensic Medicine and Neurology, having authored 814 papers that have together received 66.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (251 papers), Neuroendocrine Tumor Research Advances (159 papers), Cancer Genomics and Diagnostics (105 papers), Lung Cancer Research Studies (69 papers), Neuroblastoma Research and Treatments (52 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (51 papers), Genetic factors in colorectal cancer (51 papers) and Epigenetics and DNA Methylation (39 papers). The work is most often cited by research in Cancer Research (18.4k citations), Oncology (27.5k citations), Epidemiology (13.3k citations), Neurology (5.3k citations) and Molecular Biology (21.9k citations). Aldo Scarpa has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Massimo Falconi, Giuseppe Zamboni, Paola Capelli, Claudio Luchini, Carlo Maria Croce, George A. Călin, Stefano Volinia, Chang‐Gong Liu, Claudia Roldo and Andrea Mafficini. Their work appears in journals such as Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Annals of Oncology, Nature Communications, Pancreatology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.